Erythropoietin (Epo) is a glycoprotein factor that specifically regulates the proliferation and differentiation of erythroid progenitor cells. Here we describe the isolation of Epo-responsive mouse erythroleukemia cell line SKT6, the characterization of the specific binding of biologically active '25I-labeled human Epo ('25I-Epo) to its membrane receptor, and, finally, report information concerning the molecular structure of the receptor. About 75% of erythroid colonyforming precursor cell-like colonies derived from SKT6 cells were hemoglobin-positive after 3-to 4-day exposure to Epo in methylcellulose culture. Radioiodinated Epo bound specifically to SKT6 cells, and Scatchard analysis of the data showed a high affinity for 125I-Epo (Kd = 0.15 nM) but displayed only a small number of specific receptors (=470 per cell). Membrane components that specifically interact with 125I-Epo were identified by covalent crosslinking with disuccinimidyl suberate, and three receptor species with apparent Mr 63,000, 94,000, and 119,000 were found in membrane from SKT6 cells, suggesting the complex structure of the receptor molecules. Specific bindings were also detected in all of the Epo-unresponsive Friend erythroleukemia cells examined, and crosslinking study revealed the presence of only the 63,000 species as a binding site.
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In vitro hemopoiesis is regulated by a set of specific glycoproteins that affect the proliferation and differentiation of the progenitor cells (1) . Among these humoral factors, two glycoproteins specific for erythropoietic lineage have been identified by recombinant DNA technology, and their physiological functions have been clarified (2) (3) (4) (5) . Burst-promoting activity, which was identified as one of the interleukin 3 (IL-3) activities (2) , enhances proliferation of immature erythroid cells (BFU-E). Erythropoietin (Epo) acts on relatively mature erythroid progenitor cells (CFU-E) and induces differentiation of the cells to mature erythrocytes (3, 4) .
Epo has been purified to homogeneity from the urine of patients with aplastic anemia (6) . Clones of complementary and/or genomic DNA encoding the human and mouse Epo were recently isolated, and recombinant human Epo is produced in mammalian cells (3, 4, 7) . However, very little is known about the molecular mechanism ofthe erythroid cell differentiation induced by this hormone, owing mainly to the difficulty of obtaining sufficient quantities of pure target cells and purified hormone.
To study the nature of the cells responsive to Epo and to gain insight into the mechanism by which the Epo receptor mediates the response to Epo, we established an Eporesponsive mouse erythroleukemia cell line SKT6 and characterized the specific binding of recombinant Epo to its membrane receptor; from these results we briefly discuss the molecular structure of the Epo receptor. 106 in 100 ,ul of binding medium) were incubated with 120 pM 125I-Epo at either 10'C or 370C. Following incubation, aliquots of cells were filtered through a glass filter (Whatman GF/A). The filters were washed with 12 ml of phosphatebuffered saline, dried, and the radioactivities retained on the filters were determined. Results were corrected for nonspecific binding of 125I-Epo obtained in the presence of excess unlabeled Epo and represent specific binding of "-5I-Epo.
MATERIALS AND METHODS
Affinity Labeling of 12'I-Epo to Its Receptor. Cells were incubated with 0.75 nM 125I-Epo with or without 75 nM unlabeled Epo for 30 min at 370C, and crosslinking of bound 125I-Epo to its receptor was done essentially as described by Pilch and Czech (10) . After being washed twice with ice-cold phosphate-buffered saline, the cell surface proteins were crosslinked with 0.3 mM disuccinimidyl suberate (Nakarai) for 60 min at 40C. Cells were washed with 50 mM Tris HCl, pH 6.8, and the cell surface proteins were extracted in 50 mM Tris-HCl, pH 6.8, containing 1.5% Triton X-100. 125I-Epo crosslinked complexes were analyzed by NaDodSO4/PAGE using 10% acrylamide separating gels with or without 5% 2-mercaptoethanol, according to the method ofLaemmli (11) . Gels were dried and subjected to autoradiography on Kodak XAR-5 film at -70°C in the presence of an intensifying screen.
RESULTS
Isolation of Epo-Responsive Cell Line. Mouse erythroleukemia cells induced by FVA were maintained in suspension, and clonal cell lines were isolated after limiting dilution. The potential of the clonal cell lines to differentiate in the presence of Epo was examined by incubating cells with recombinant Epo (0.5 unit/ml) in suspension cultures for 4 days and monitoring the percentage of hemoglobin-positive cells. Following several recloning procedures, a cell line, SKT6, that showed the highest response to Epo (over 70%) was established and maintained in suspension over 1.5 years. It was necessary to use the fetal calf serum containing negligible Epo activity to keep the SKT6 cells highly responsive to Epo in the long-time culture.
Colony-Forming Assay for SKT6 Cells. When SKT6 cells were cultured in methylcellulose in the presence or absence of 2 units of Epo per ml for 3-4 days, they formed erythroid colonies of 8-32 cells, similar to those derived from relatively mature erythroid progenitor cells (CFU-E) from normal bone marrow (Fig. 1) (Fig. 4) . The binding was rapid at 370C and appeared to be maximal by 15 (Fig. 5B) . The estimated number of receptors was -470 per cell.
No specific binding of125I-Epo was observed for any of the following cell lines; human erythroleukemia HEL and K-562 cells, mouse myelomonocytic leukemia WEHI-3 cells, human promyelocytic letikemia HL-60 cells, mouse IL-3 dependent P cell-like IC-2 cells (16) and mouse reticulum sarcoma FVTCT cells (17) . Even when the concentration of 125I-Epo was increased to 5 nM, no specific binding could be detected on these cells. The possibility that smaller Mr species (128,000 and/or 97,000 bands) were proteolytic cleavage products of larger Mr species (153,000 and/or 128,000 bands) was addressed by including a mixture of protease inhibitors in the extraction buffer. All species were found in similar amounts (data not shown).
Affinity Labeling of '"I-Epo to Epo-Unresponsive Cells. The crosslinked complex identified from Epo-unresponsive T3-Cl-2-0 cells was seen to migrate as a single iodinated band with Mr 97,000 (Fig. 6, lane c) (Fig. 2) . Consequently, this cell line proved to be suitable for studying Epo action at subcellular and molecular levels.
As shown in Fig. 3 , even a low concentration of Epo (0.1 unit/ml-i.e., 42 pM) was enough to induce differentiation in most of the SKT6 cells. According to the binding curve (Fig.  5A) , about 69 Epo molecules bind to its membrane receptor per cell at 42 pM Epo. In other words, biological response can occur on SKT6 cells at a lower receptor occupancy (14% of total receptors). Under normal physiological conditions Epo exists in the circulation at a concentration of 0.015-0.030 unit/ml of serum, or about 9 pM (24). This indicates that only 15 Epo molecules bind to the receptor per cell (i.e., only 3% receptor occupancy). These observations suggest that the signal generated by Epo binding to its specific receptor must be very potent. Friend erythroleukemia cells have been used to study the mechanism of cell differentiation because they differentiate into more mature erythroid cells by various chemical inducers (25) . However, this model system obviously does not represent the receptor-mediated erythroid differentiation occurring in vivo. Drastic changes of protooncogene (c-myb, c-myc and c-fos) expression upon Epo induction were observed on SKT6 cells (K.T., unpublished data). Those changes appeared, however, to be entirely different from those observed on Epo-unresponsive erythroleukemia cell differentiation induced by chemicals (26, 27) . Studies of the molecular mechanism of erythroid differentiation should be based on receptor-mediated pathway rather than chemically induced bypass. Further investigation on Epo-induced cell response of SKT6 cells may reveal the detailed mechanisms of receptor-mediated signal transduction at the molecular level.
